Maha Hussain
MD
Genevieve E. Teuton Professor of Medicine
👥Biography 个人简介
Maha Hussain is the lead investigator of the PROSPER trial and has been instrumental in establishing enzalutamide as a standard-of-care therapy for non-metastatic CRPC. Her landmark research demonstrated significant improvements in metastasis-free survival and overall survival with second-generation anti-androgens. She has led multiple phase III trials that have transformed the treatment paradigm for advanced prostate cancer. Hussain is widely regarded as one of the most influential clinical trialists in prostate cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Maha Hussain 的研究动态
Follow Maha Hussain's research updates
留下邮箱，当我们发布与 Maha Hussain（Northwestern University Feinberg School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment